These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37172269)

  • 1. Validating an approach to overcome the immeasurable time bias in cohort studies: a real-world example and Monte Carlo simulation study.
    Oh IS; Jeong HE; Lee H; Filion KB; Noh Y; Shin JY
    Int J Epidemiol; 2023 Oct; 52(5):1534-1544. PubMed ID: 37172269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical approaches to minimizing immeasurable time bias in cohort studies.
    Oh IS; Baek YH; Jeong HE; Filion KB; Shin JY
    Int J Epidemiol; 2021 Jul; 50(3):987-999. PubMed ID: 33367629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An empirical assessment of immeasurable time bias in the setting of nested case-control studies: Statins and all-cause mortality among patients with heart failure.
    Oh IS; Filion KB; Jeong HE; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1318-1327. PubMed ID: 31432599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New methodological approaches were able to effectively reduce immeasurable time bias in case-only designs.
    Jeong HE; Oh IS; Lee H; Filion KB; Shin JY
    J Clin Epidemiol; 2021 Mar; 131():1-10. PubMed ID: 33171274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses.
    Jeong HE; Lee H; Oh IS; Filion KB; Shin JY
    J Epidemiol; 2023 Feb; 33(2):82-90. PubMed ID: 34053964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simulation study of finite-sample properties of marginal structural Cox proportional hazards models.
    Westreich D; Cole SR; Schisterman EF; Platt RW
    Stat Med; 2012 Aug; 31(19):2098-109. PubMed ID: 22492660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of methods to estimate the hazard ratio under conditions of time-varying confounding and nonpositivity.
    Naimi AI; Cole SR; Westreich DJ; Richardson DB
    Epidemiology; 2011 Sep; 22(5):718-23. PubMed ID: 21747286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug Information.
    Baek YH; Noh Y; Oh IS; Jeong HE; Filion KB; Lee H; Shin JY
    Drug Saf; 2022 Oct; 45(10):1057-1067. PubMed ID: 35978219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies.
    Shintani AK; Girard TD; Eden SK; Arbogast PG; Moons KG; Ely EW
    Crit Care Med; 2009 Nov; 37(11):2939-45. PubMed ID: 19770737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study.
    Desai RJ; Wyss R; Abdia Y; Toh S; Johnson M; Lee H; Karami S; Major JM; Nguyen M; Wang SV; Franklin JM; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):879-886. PubMed ID: 31020732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching by propensity score in cohort studies with three treatment groups.
    Rassen JA; Shelat AA; Franklin JM; Glynn RJ; Solomon DH; Schneeweiss S
    Epidemiology; 2013 May; 24(3):401-9. PubMed ID: 23532053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
    Palmaro A; Boucherie Q; Dupouy J; Micallef J; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):544-553. PubMed ID: 28266748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of different censoring methods for analyzing survival using real-world data with linked mortality information: a simulation study.
    Hsu WC; Crowley A; Parzynski CS
    BMC Med Res Methodol; 2024 Sep; 24(1):203. PubMed ID: 39272007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the cohort design and the nested case-control design in the presence of both time-invariant and time-dependent treatment and competing risks: bias and precision.
    Austin PC; Anderson GM; Cigsar C; Gruneir A
    Pharmacoepidemiol Drug Saf; 2012 Jul; 21(7):714-724. PubMed ID: 22653805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo simulation-based estimation for the minimum mortality temperature in temperature-mortality association study.
    Lee W; Kim H; Hwang S; Zanobetti A; Schwartz JD; Chung Y
    BMC Med Res Methodol; 2017 Sep; 17(1):137. PubMed ID: 28882102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminating observation within matched pairs of subjects in a matched cohort analysis: a Monte Carlo simulation study.
    Sutradhar R; Baxter NN; Austin PC
    Stat Med; 2016 Jan; 35(2):294-304. PubMed ID: 26278725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study.
    Cho IS; Chae YR; Kim JH; Yoo HR; Jang SY; Kim GR; Nam CM
    BMC Med Res Methodol; 2017 Aug; 17(1):126. PubMed ID: 28830373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example.
    Secrest MH; Platt RW; Reynier P; Dormuth CR; Benedetti A; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():35-44. PubMed ID: 31486165
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.